L712-0351 Screening compound: N-(3,5-dimethylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

L712-0351 Screening compound: N-(3,5-dimethylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide
L712-0351 Screening compound: N-(3,5-dimethylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L712-0351
N-(3,5-dimethylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L712-0351

Molecular Formula

C28H32N6O (C28 H32 N6 O)

Compound Name

N-(3,5-dimethylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

IUPAC name

N-(35-dimethylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[45-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

SMILES

Cc(cc1)ccc1-c1nc2cccnc2n1CCN(CC1)CCN1C(Nc1cc(C)cc(C)c1)=O

InChI

InChI=1S/C28H32N6O/c1-20-6-8-23(9-7-20)26-31-25-5-4-10-29-27(25)34(26)16-13-32-11-14-33(15-12-32)28(35)30-24-18-21(2)17-22(3)19-24/h4-10,17-19H,11-16H2,1-3H3,(H,30,35)

InChI Key

NFGGYVDTOJXDPU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15133592

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.6

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.860

Distribution Coefficient, logD

4.855

Water Solubility, LogSw

-4.46

Polar Surface Area

49.040

Acid Dissociation Constant (pKa)

14.39

Base Dissociation Constant (pKb)

5.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.10

L712-0351 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L712-0351 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L712-0351?
Check Price and Availability of L712-0351, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L712-0351 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L712-0351
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L712-0351
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L712-0351 available by request